What is Altaviz?
Altaviz operates at the intersection of medical device innovation and pharmaceutical development. By providing sophisticated design and development services, the company addresses complex engineering challenges inherent in drug delivery systems and ophthalmic care. Their service portfolio, which includes advanced implant delivery systems and gas-powered devices, positions them as a vital partner for biotechnology and pharmaceutical firms seeking to commercialize state-of-the-art medical solutions. Through a focus on customized engineering frameworks, Altaviz maintains a competitive edge in a highly regulated and technically demanding market segment.
How much funding has Altaviz raised?
Altaviz has raised a total of $433K across 2 funding rounds:
Debt
$150K
Debt
$283K
Debt (2020): $150K with participation from PPP
Debt (2021): $283K led by PPP
Key Investors in Altaviz
PPP
Public-Private Partnership
What's next for Altaviz?
With this late-stage capital injection, Altaviz is well-positioned to scale its research and development initiatives and expand its footprint in the global medical technology market. The strategic allocation of these funds will likely prioritize the acceleration of product commercialization cycles and the enhancement of their proprietary delivery platforms. As the company transitions into this next phase of maturity, stakeholders will be monitoring their ability to leverage these resources to capture additional market share within the specialized biotech and pharmaceutical sectors, ensuring long-term sustainability and technological leadership.
See full Altaviz company page
